Highbridge Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Highbridge Capital Management's AMGN Position: Q2 2018 in Review
Highbridge Capital Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 55,642 shares — an estimated $9.84M sold.
Highbridge Capital Management first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $43.2M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.
- Highbridge Capital Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
- Highbridge Capital Management sold 55,642 Amgen shares in Q2 2018, an estimated $9.84M.
- Highbridge Capital Management first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
- Highbridge Capital Management's Amgen position peaked at $43.2M in Q3 2013.
- 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.
Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.